Skip to main content
. 2021 Feb 5;23(6):1065–1074. doi: 10.1038/s41436-020-01096-4

Fig. 4. Clinical case EpiSign assignment.

Fig. 4

Assessment of the notable clinical cases. (a) Principal component analysis (PCA) plots for Clin136 (no genetic variant identified), Clin6 (no genetic variant identified), and Clin187 (DNMT3A:c.2146G>A [p.Val716Ile]). (b) Corresponding methylation variant pathogenicity (MVP) scores for the notable clinical cases. Both PCA plots and MVP scores provide conclusive evidence for EpiSign classification of these clinical cases.